Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

UiPath, Inc. (PATH)

2026-02-05T15:26:26.358571+00:00

Key Updates

UiPath shares declined 2.25% to $11.96 since the last report, continuing the downward momentum and establishing a new multi-month low. The stock has now fallen 27.06% YTD and 31.02% over the past month, reflecting sustained selling pressure despite positive technical achievements. The investment thesis remains under pressure as competitive dynamics intensify, with Palantir's exceptional Q4 results (70% revenue growth, Rule of 40 score of 127) demonstrating the widening performance gap in enterprise AI adoption. UiPath's recent OSWorld benchmark achievement provides validation of technical capabilities but has failed to translate into investor confidence amid broader market concerns about competitive positioning and growth trajectory.

Current Trend

UiPath is in a pronounced downtrend with the stock falling 27.06% YTD to $11.96, marking the weakest performance level observed in the current reporting period. The 31.02% decline over the past month represents accelerating negative momentum, with the stock breaking through multiple support levels including the previously critical $12.59 and $12.23 thresholds. Short-term volatility remains elevated with a 9.77% decline over five days, while the 6.55% gain over six months has been completely erased. The current price action suggests capitulation selling with no clear technical support visible until previous lows are tested. Daily volume patterns indicate sustained distribution as institutional investors rotate capital toward demonstrably stronger AI competitors.

Investment Thesis

The core investment thesis for UiPath centers on the company's leadership position in the expanding RPA market, projected to grow from $3.60 billion in 2025 to $20.79 billion by 2032 at a 28.47% CAGR. UiPath's technological differentiation lies in its agentic automation platform, validated by achieving No. 1 ranking on the OSWorld-Verified benchmark for computer-use agents. The company's platform-centric approach commands 30-40% higher enterprise deal values compared to standalone tool providers, positioning UiPath to capture disproportionate value as enterprises transition from task-level automation to AI-augmented strategic execution capabilities. However, the thesis faces significant headwinds from competitive pressure, particularly from Palantir's rapid enterprise AI adoption (93% U.S. business growth), and emerging alternatives like Rimini Street's agentic solutions claiming 50-60% faster approval turnarounds at lower cost points. The fundamental challenge is whether UiPath's technical superiority can translate into sustained revenue growth and market share gains in an increasingly crowded enterprise AI landscape.

Thesis Status

The investment thesis is deteriorating as market dynamics diverge from UiPath's value proposition. While the company maintains technical leadership through benchmark achievements, the 27.06% YTD decline signals investor skepticism about UiPath's ability to monetize this advantage. Palantir's Q4 results reveal the critical gap: 70% revenue growth versus UiPath's ongoing struggles, with Palantir's U.S. business now representing 77% of revenue and growing 93% year-over-year. The competitive landscape is bifurcating between "AI haves" demonstrating exceptional growth (Palantir's Rule of 40 score of 127) and vendors facing commoditization pressure. UiPath's position is further challenged by the emergence of lower-cost alternatives (Rimini Street) and platform consolidation by hyperscalers (Microsoft, IBM). The RPA market's projected 28.47% CAGR provides sector tailwinds, but UiPath's share price performance suggests investors question whether the company can maintain its premium positioning as enterprise AI budgets increasingly favor integrated platforms with demonstrated ROI. The thesis requires evidence of accelerating revenue growth and expanding margins to regain credibility.

Key Drivers

Market expansion remains a fundamental driver, with the RPA market projected to reach $20.79 billion by 2032, growing at 28.47% CAGR as enterprises report 25-35% operational cost reductions and 20-30% faster process cycle times. UiPath's technical validation through its No. 1 OSWorld benchmark ranking demonstrates competitive differentiation in agentic automation capabilities. However, competitive intensity is accelerating, with Palantir reporting 70% revenue growth and $1.41 billion quarterly revenue, highlighting the performance gap between market leaders. The emergence of alternative solutions poses additional pressure, as Rimini Street's agentic AI solutions claim 50-60% faster turnarounds at lower cost points. Platform consolidation continues as vendors like Planview achieve 60% AI adoption rates within three months, demonstrating rapid enterprise acceptance of integrated AI platforms. The critical driver is whether UiPath can translate technical leadership into accelerated commercial traction before market share consolidates around integrated platform providers.

Technical Analysis

UiPath exhibits severe technical deterioration with the stock at $11.96, down 27.06% YTD and establishing new lows across all timeframes. The 31.02% monthly decline represents breakdown momentum with no visible support until previous base levels. The stock has violated the $12.59 support (January 31 low), the $12.23 level (February 4), and now trades at $11.96, suggesting capitulation dynamics. Short-term resistance has formed at $12.23, $12.59, and $12.88 (February 2 intraday high), creating a descending resistance pattern. The 9.77% five-day decline indicates accelerating negative momentum with no signs of stabilization. Volume characteristics suggest institutional distribution rather than retail panic, as the selling has been persistent rather than episodic. The six-month gain of 6.55% has been completely eliminated, indicating a full reversal of any positive momentum from late 2025. The current technical structure requires a decisive break above $12.88 with sustained volume to signal trend reversal; otherwise, the path of least resistance remains lower toward psychological support at $10.00.

Bull Case

Bear Case

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.